An accelerated approval for Zydus Cadila’s COVID-19 vaccine candidate by the Indian regulator has given the company global bragging rights to the first plasmid DNA vaccine for use in humans. Zy-CoV-D also becomes the first coronavirus vaccine to be given a nod for adolescents in India.
While that’s good press and something the company can rightfully list as an achievement, Zydus Cadila will have to construct an effective strategy to actually get its